G6PD and hepatocellular carcinoma: Existing evidence has shown that the level of G6PD is increased in a range of tumor cells, such as urinary tract cancer, breast cancer, cervical cancer, hepatocellular carcinoma, bladder cancer, lung cancer, and ovarian cancer (8–14).